2024 Phenotyping Hepatic Immune-Related Adverse Events in the Setting of Immune Checkpoint Inhibitor Therapy. Theodore C. Feldman, David E. Kaplan, Albert Lin, Jennifer La, Jerry S. H. Lee, Mayada Aljehani, David P. Tuck, Mary T. Brophy, Nathanael R. Fillmore‡, Nhan V. Do‡‡ Equal senior authorship JCO Clinical Cancer Informatics8, e2300159 Immune Checkpoint Inhibitors Immune-Related Adverse Events Hepatocellular Carcinoma Rule-Based Algorithms Retrospective Cohort Study
2021 Evaluating the impact of age on immune checkpoint therapy biomarkers. Rossin Erbe, Zheyu Wang, Sharon Wu, Joanne Xiu, Neeha Zaidi, Jennifer La, David Tuck, Nathanael Fillmore, Nicolas A. Giraldo, Michael Topper, Stephen Baylin, Marc Lippman, Claudine Isaacs, Reva Basho, Ilya Serebriiskii, Heinz-Josef Lenz, Igor Astsaturov, John Marshall, Josephine Taverna, Jerry Lee, Elizabeth M. Jaffee, Torres Evanthia T. Roussos, Ashani Weeraratna, Hariharan Easwaran, Elana J. Fertig Cell Reports36(8), 109599 Age Factors Biomarkers Comparative Analysis Genomic Analysis Immune Checkpoint Inhibitors
2020 Real-World Outcomes for Patients Treated With Immune Checkpoint Inhibitors in the Veterans Affairs System. Jennifer La, David Cheng, Mary T. Brophy, Nhan V. Do, Jerry S. H. Lee, David Tuck‡, Nathanael R. Fillmore‡‡ Equal senior authorship JCO Clinical Cancer Informatics4, 918-928 U.S. Veterans and VA Data Retrospective Cohort Study Electronic Health Records Immune Checkpoint Inhibitors Overall Survival
